932
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Differentiation of Human Parthenogenetic Embryonic Stem Cells into Functional Hepatocyte-like Cells

, , , ORCID Icon, , , & show all
Pages 137-148 | Received 10 Feb 2020, Accepted 08 Jul 2020, Published online: 25 Nov 2020

References

  • Russo FP, Parola M. Stem cells in liver failure. Best Pract Res Clin Gastroenterol. 2012;26(1):35–45. doi:10.1016/j.bpg.2012.01.001.
  • Cho CH, Parashurama N, Park EY, Suganuma K, Nahmias Y, Park J, Tilles AW, Berthiaume F, Yarmush ML. Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. Faseb J. 2008;22(3):898–909. doi:10.1096/fj.06-7764com.
  • Isaev D, Garitaonandia I, Abramihina TV, Zogovic-Kapsalis T, West RA, Semechkin AY, Müller AM, Semechkin RA. In vitro differentiation of human parthenogenetic stem cells into neural lineages. Regen Med. 2012;7(1):37–45. doi:10.2217/rme.11.110.
  • Wang Z, Li W, Chen T, Yang J, Wen Z, Yan X, Shen T, Liang R. Activin A can induce definitive endoderm differentiation from human parthenogenetic embryonic stem cells. Biotechnol Lett. 2015;37(8):1711–17. doi:10.1007/s10529-015-1829-x.
  • Lin G, Ouyang Q, Zhou X, Gu Y, Yuan D, Li W, Liu G, Liu T, Lu G. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res. 2007;17(12):999–1007. doi:10.1038/cr.2007.97.
  • Xu X, Browning VL, Odorico JS. Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mech Dev. 2011;128(7):412–27. doi:10.1016/j.mod.2011.08.001.
  • Santamaria P, Rodriguezpiza I, Clementecasares X, Yamanouchi J, Muleroperez L, Aasen T, Raya A, Izpisua Belmonte JC. Turning human epidermis into pancreatic endoderm. Rev Diabet Stud. 2010;7(2):158–67. doi:10.1900/RDS.2010.7.158.
  • Yamada MD, Yoshikawa M, Kanda S, Kato Y, Nakajima Y, Ishizaka S, Tsunoda Y. In vitro differentiation of embryonic stem cells into hepatocyte‐like cells identified by cellular uptake of indocyanine green. Stem Cells. 2002;20(2):146–54. doi:10.1634/stemcells.20-2-146.
  • Diekmann U, Naujok O, Blasczyk R, Müller T. Embryonic stem cells of the non‐human primate Callithrix jacchus can be differentiated into definitive endoderm by Activin‐A but not IDE‐1/2. J Tissue Eng Regen Med. 2015;9(4):473–79. doi:10.1002/term.1709.
  • Toivonen S, Lundin K, Balboa D, Ustinov J, Tamminen K, Palgi J, Trokovic R, Tuuri T, Otonkoski T. Activin A and Wnt-dependent specification of human definitive endoderm cells. Exp Cell Res. 2013;319(17):2535–44. doi:10.1016/j.yexcr.2013.07.007.
  • Rambhatla L, Chiu C, Kundu P, Peng Y, Carpenter MK. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. 2003;12(1):1–11. doi:10.3727/000000003783985179.
  • Turovets N, Damour KA, Agapov V, Turovets I, Kochetkova O, Janus J, Semechkin A, Moorman MA, Agapova L. Human parthenogenetic stem cells produce enriched populations of definitive endoderm cells after trichostatin A pretreatment. Differentiation. 2011;81(5):292–98. doi:10.1016/j.diff.2011.01.002.
  • Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H, Meng S, Chen Y, Zhou R, Song X, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology. 2007;45(5):1229–39. doi:10.1002/hep.21582.
  • Duan Y, Ma X, Zou W, Wang C, Bahbahan IS, Ahuja TP, Tolstikov V, Zern MA. Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells. Stem Cells. 2010;28(4):674–86. doi:10.1002/stem.315.
  • Daley GQ, Richter LA, Auerbach JM, Benvenisty N, Charo RA, Chen G, Deng HK, Goldstein LS, Hudson KL, Hyun I, et al. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science. 2007;315(5812):603–04. doi:10.1126/science.1139337.
  • Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76. doi:10.1016/j.cell.2006.07.024.
  • Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917–20. doi:10.1126/science.1151526.
  • Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72. doi:10.1016/j.cell.2007.11.019.
  • Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448(7151):313–17. doi:10.1038/nature05934.
  • Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474(7350):212–15. doi:10.1038/nature10135.
  • Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ, et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell. 2011;8(1):106–18. doi:10.1016/j.stem.2010.12.003.
  • Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cel. 2010;7(4):521–31. doi:10.1016/j.stem.2010.07.017.
  • Sareen D, Mcmillan E, Ebert AD, Shelley BC, Johnson JA, Meisner LF, Svendsen CN. Chromosome 7 and 19 trisomy in cultured human neural progenitor cells. PLoS One. 2009;4:10.
  • Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature. 2011;471(7336):63–67. doi:10.1038/nature09805.
  • Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Närvä E, Ng S, Sourour M, Hämäläinen R, Olsson C, et al. Copy number variation and selection during reprogramming to pluripotency. Nature. 2011;471(7336):58–62. doi:10.1038/nature09871.
  • Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O’Malley R, Castanon R, Klugman S, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature. 2011;471(7336):68–73. doi:10.1038/nature09798.
  • Pasi CE, Dereli-Öz A, Negrini S, Friedli M, Fragola G, Lombardo A, Van Houwe G, Naldini L, Casola S, Testa G, et al. Genomic instability in induced stem cells. Cell Death Differ. 2011;18(5):745–53. doi:10.1038/cdd.2011.9.
  • Cheng L, Hansen NF, Zhao L, Du Y, Zou C, Donovan FX, Chou BK, Zhou G, Li S, Dowey SN, et al. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell. 2012;10(3):337–44. doi:10.1016/j.stem.2012.01.005.
  • Young MA, Larson DE, Sun CW, George DR, Ding L, Miller CA, Lin L, Pawlik KM, Chen K, Fan X, et al. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell. 2012;10(5):570–82. doi:10.1016/j.stem.2012.03.002.
  • Yangqi O, Ge L, Xiaoying Z, Guang-xiu LU. Comparison of the differentiation capability between human parthenogenetic embryonic stem cells and normal embryonic stem cells. Acta Anatomica Sinica. 2010;41:785–89.
  • Lampton PW, Crooker RJ, Newmark JA, Warner CM. Expression of major histocompatibility complex class I proteins and their antigen processing chaperones in mouse embryonic stem cells from fertilized and parthenogenetic embryos. Tissue Antigens. 2008;72(5):448–57. doi:10.1111/j.1399-0039.2008.01132.x.
  • Sritanaudomchai H, Ma H, Clepper L, Gokhale S, Bogan R, Hennebold J, Wolf D, Mitalipov S. Discovery of a novel imprinted gene by transcriptional analysis of parthenogenetic embryonic stem cells. Hum Reprod. 2010;25(8):1927–41. doi:10.1093/humrep/deq144.
  • Lu Z, Zhu W, Yu Y, Jin D, Guan Y, Yao R, Zhang YA, Zhang Y, Zhou Q. Derivation and long-term culture of human parthenogenetic embryonic stem cells using human foreskin feeders. J Assist Reprod Genet. 2010;27(6):285–91. doi:10.1007/s10815-010-9408-5.
  • Turovets N, Semechkin A, Kuzmichev LN, Janus J, Agapova L, Revazova E. Derivation of human parthenogenetic stem cell lines. Methods Mol Biol. 2011;767:37–54.
  • Kim K, Ng K, Rugg-Gunn PJ, Shieh JH, Kirak O, Jaenisch R, Wakayama T, Moore MA, Pedersen RA, Daley GQ. Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell. 2007;1(3):346–52. doi:10.1016/j.stem.2007.07.001.
  • Revazova ES, Kuzmichev LN, Turovets NA, Kochetkova OD, Kindarova LB, Kuzmichev LN, Janus JD, Pryzhkova MV. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells. 2007;9(3):432–49. doi:10.1089/clo.2007.0033.
  • Hao J, Zhu W, Sheng C, Yu Y, Zhou Q. Human parthenogenetic embryonic stem cells: one potential resource for cell therapy. Sci China Life Sci. 2009;52:599–602.
  • Huang L, Vore M. Multidrug resistance P-Glycoprotein 2 is essential for the biliary excretion of indocyanine green. Drug Metab Dispos. 2001;29:634–37.
  • de Graaf W, Hausler S, Heger M, van Ginhoven TM, van Cappellen G, Bennink RJ, Kullak-Ublick GA, Hesselmann R, van Gulik TM, Stieger B. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol. 2011;54(4):738–45. doi:10.1016/j.jhep.2010.07.047.
  • Cusin F, Azevedo LF, Bonnaventure P, Desmeules J, Daali Y, Pastor CM. Hepatocyte concentrations of indocyanine green reflect transfer rates across membrane transporters. Basic Clin Pharmacol Toxicol. 2017;120:171–78.
  • Torok G, Erdei Z, Lilienberg J, Apáti Á1, Homolya L. The importance of transporters and cell polarization for the evaluation of human stem cell-derived hepatic cells. PLoS One. 2020;15(1). doi:10.1371/journal.pone.0227751.
  • Song Z, Cai J, Liu Y, Zhao D, Yong J, Duo S, Song X, Guo Y, Zhao Y, Qin H, et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 2009;19(11):1233–42. doi:10.1038/cr.2009.107.
  • Park Y, Chen Y, Ordovas L, Verfaillie CM. Hepatic differentiation of human embryonic stem cells on microcarriers. J Biotechnol. 2014;39–48. doi:10.1016/j.jbiotec.2014.01.025.
  • Mun SJ, Ryu JS, Lee MO, Son YS, Oh SJ, Cho HS, Son MY, Kim DS, Kim SJ, Yoo HJ, et al. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. J Hepatol. 2019;71(5):970–85. doi:10.1016/j.jhep.2019.06.030.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.